BCPC
Balchem Corporation
Price Chart
Latest Quote
$164.38
+0.21 (+0.13%)
Current Price
| Previous Close | $164.17 |
| Open | $163.69 |
| Day High | $165.07 |
| Day Low | $162.09 |
| Volume | 268,854 |
Stock Information
| Quarterly Dividend / Yield | $0.96 / 0.59% |
| Shares Outstanding | 32.13M |
| Quarterly Dividend Yield | 0.59% |
| Quarterly Dividend | $0.96 |
| Total Debt | $184.71M |
| Cash Equivalents | $72.87M |
| Revenue | $1.06B |
| Net Income | $158.08M |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Market Cap | $5.28B |
| P/E Ratio | 33.75 |
| EPS (TTM) | $4.87 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.39B |
| Sales | $1.06B |
| Income | $158.08M |
| Book/sh | $40.00 |
| Cash/sh | $2.27 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 1.49 |
| Current Ratio | 2.55 |
| Debt/Eq | 14.37 |
| EPS Growth TTM | 8.70% |
Returns & Margins
| ROA | 8.09% |
| ROE | 12.68% |
| Gross Margin | 36.28% |
| Operating Margin | 20.88% |
| Profit Margin | 14.95% |
Ownership
| Insider Ownership | 0.47% |
| Institutional Ownership | 93.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 26.90 |
| PEG | 3.77 |
| P/S | 5.00 |
| P/B | 4.11 |
Analyst Data
| Recommendation | none |
| Target Price | $200.75 |
Technical Indicators
| SMA20 | $160.88 |
| SMA50 | $165.41 |
| SMA200 | $161.37 |
| RSI | 60.04 |
| ATR | 3.3914 |
| Shares Float | 31.94M |
| Short Float | 1.77% |
| Short Ratio | 2.32 |
| Volatility | 0.83 |
| Rel Volume | 1.32 |
Performance History
| Week | +1.69% |
| Month | +3.08% |
| Quarter | +0.92% |
| 6 Months | +4.21% |
| YTD | +6.73% |
| Year | +3.37% |
| 3 Years | +24.34% |
| 5 Years | +27.43% |
| 10 Years | +190.35% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $164.38 | 275,000 |
| 2026-06-16 | $164.17 | 268,000 |
| 2026-06-15 | $163.68 | 208,800 |
| 2026-06-12 | $165.04 | 154,200 |
| 2026-06-11 | $165.34 | 165,000 |
| 2026-06-10 | $161.65 | 184,800 |
| 2026-06-09 | $162.32 | 212,100 |
| 2026-06-08 | $158.69 | 123,900 |
| 2026-06-05 | $159.91 | 284,000 |
| 2026-06-04 | $158.02 | 173,400 |
| 2026-06-03 | $156.62 | 494,100 |
| 2026-06-02 | $157.31 | 210,000 |
| 2026-06-01 | $156.30 | 235,600 |
| 2026-05-29 | $156.73 | 259,600 |
| 2026-05-28 | $160.26 | 117,700 |
| 2026-05-27 | $160.92 | 138,900 |
| 2026-05-26 | $161.50 | 189,600 |
| 2026-05-22 | $161.75 | 128,800 |
| 2026-05-21 | $161.75 | 162,200 |
| 2026-05-20 | $161.20 | 173,200 |
| 2026-05-19 | $159.21 | 144,300 |
| 2026-05-18 | $159.47 | 141,900 |
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
đ° Latest News
Are Options Traders Betting on a Big Move in Balchem Stock?
Zacks âĸ 2026-05-19T15:24:00Z
Should Balchemâs Q1 2026 Earnings Jump and Buyback Activity Require Action From Balchem (BCPC) Investors?
Simply Wall St. âĸ 2026-05-14T17:19:07Z
Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing
Motley Fool âĸ 2026-05-12T13:21:34Z
Hereâs Why Investors Favored Balchem Corp. (BCPC)
Insider Monkey âĸ 2026-05-06T14:12:04Z
Balchem Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-04-30T20:55:22Z
Balchem (BCPC) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-04-30T16:55:58Z
Balchem (BCPC) Valuation Check After Steady Fundamentals And Recent Share Price Gains
Simply Wall St. âĸ 2026-04-28T14:07:58Z
Conestoga Capital Dumps 7.3 Million CCC Intelligent Solutions Shares Worth $47.8 Million
Motley Fool âĸ 2026-04-27T14:26:21Z
Conestoga Sells 64K Q2 Shares
Motley Fool âĸ 2026-04-27T12:14:32Z
Balchem Corporation: The Formulation-Embedded Compounder That Has Not Missed a Year
GuruFocus.com âĸ 2026-04-25T09:52:22Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $666,528,000 | $617,478,000 | $620,383,000 | $661,907,000 |
| Cost Of Revenue | $666,528,000 | $617,478,000 | $620,383,000 | $661,907,000 |
| Total Revenue | $1,037,161,000 | $953,684,000 | $922,439,000 | $942,358,000 |
| Operating Revenue | $1,037,161,000 | $953,684,000 | $922,439,000 | $942,358,000 |
| Expenses | ||||
| Interest Expense | $10,219,000 | $16,528,000 | $22,613,000 | $10,268,000 |
| Total Expenses | $827,835,000 | $770,775,000 | $763,246,000 | $797,172,000 |
| Other Income Expense | $-77,000 | $72,000 | $681,000 | $-1,169,000 |
| Other Non Operating Income Expenses | $-77,000 | $72,000 | $681,000 | $-1,169,000 |
| Net Non Operating Interest Income Expense | $-10,219,000 | $-16,528,000 | $-22,613,000 | $-10,268,000 |
| Interest Expense Non Operating | $10,219,000 | $16,528,000 | $22,613,000 | $10,268,000 |
| Operating Expense | $161,307,000 | $153,297,000 | $142,863,000 | $135,265,000 |
| Selling And Marketing Expense | $75,374,000 | $68,916,000 | $74,397,000 | $67,409,000 |
| General And Administrative Expense | $67,423,000 | $67,588,000 | $53,417,000 | $55,665,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Net Interest Income | $-10,219,000 | $-16,528,000 | $-22,613,000 | $-10,268,000 |
| Normalized Income | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Net Income From Continuing And Discontinued Operation | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Total Operating Income As Reported | $209,326,000 | $182,909,000 | $159,193,000 | $145,186,000 |
| Net Income Common Stockholders | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Net Income | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Net Income Including Noncontrolling Interests | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Net Income Continuous Operations | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Pretax Income | $199,030,000 | $166,453,000 | $137,261,000 | $133,749,000 |
| Operating Income | $209,326,000 | $182,909,000 | $159,193,000 | $145,186,000 |
| Gross Profit | $370,633,000 | $336,206,000 | $302,056,000 | $280,451,000 |
| Per Share | ||||
| Diluted EPS | $4.75 | $3.93 | $3.35 | $3.25 |
| Basic EPS | $4.83 | $3.95 | $3.37 | $3.28 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $254,939,000 | $230,954,000 | $214,809,000 | $195,865,000 |
| Reconciled Depreciation | $45,690,000 | $47,973,000 | $54,935,000 | $51,848,000 |
| EBITDA (Bullshit earnings) | $254,939,000 | $230,954,000 | $214,809,000 | $195,865,000 |
| EBIT | $209,249,000 | $182,981,000 | $159,874,000 | $144,017,000 |
| Diluted Average Shares | $32,604,000 | $32,718,000 | $32,448,000 | $32,393,000 |
| Basic Average Shares | $32,058,121 | $32,527,244 | $32,254,728 | $32,152,787 |
| Diluted NI Availto Com Stockholders | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Tax Provision | $44,185,000 | $37,978,000 | $28,718,000 | $28,382,000 |
| Research And Development | $18,510,000 | $16,793,000 | $15,049,000 | $12,191,000 |
| Selling General And Administration | $142,797,000 | $136,504,000 | $127,814,000 | $123,074,000 |
| Other Gand A | $67,423,000 | $67,588,000 | $53,417,000 | $55,665,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $277,749,000 | $204,833,000 | $83,865,000 | $-44,520,000 |
| Total Assets | $1,686,252,000 | $1,575,371,000 | $1,597,211,000 | $1,624,512,000 |
| Total Non Current Assets | $1,320,638,000 | $1,261,601,000 | $1,282,969,000 | $1,288,709,000 |
| Other Non Current Assets | $18,134,000 | $17,317,000 | $16,947,000 | $15,118,000 |
| Goodwill And Other Intangible Assets | $979,664,000 | $945,080,000 | $970,119,000 | $982,804,000 |
| Other Intangible Assets | $163,289,000 | $165,050,000 | $191,212,000 | $213,295,000 |
| Current Assets | $365,614,000 | $313,770,000 | $314,242,000 | $335,803,000 |
| Other Current Assets | $6,221,000 | $5,737,000 | $7,192,000 | $7,101,000 |
| Prepaid Assets | $9,778,000 | $8,054,000 | $7,798,000 | $4,903,000 |
| Inventory | $131,449,000 | $130,802,000 | $109,521,000 | $119,668,000 |
| Receivables | $143,596,000 | $119,662,000 | $125,284,000 | $131,578,000 |
| Accounts Receivable | $143,596,000 | $119,662,000 | $125,284,000 | $131,578,000 |
| Allowance For Doubtful Accounts Receivable | $-862,000 | $-909,000 | $-908,000 | $-1,226,000 |
| Gross Accounts Receivable | $144,458,000 | $120,571,000 | $126,192,000 | $132,804,000 |
| Cash Cash Equivalents And Short Term Investments | $74,570,000 | $49,515,000 | $64,447,000 | $66,560,000 |
| Cash And Cash Equivalents | $74,570,000 | $49,515,000 | $64,447,000 | $66,560,000 |
| Hedging Assets Current | - | - | $0 | $5,993,000 |
| Debt | ||||
| Net Debt | $89,430,000 | $140,485,000 | $245,122,000 | $374,009,000 |
| Total Debt | $180,687,000 | $208,044,000 | $330,334,000 | $460,610,000 |
| Long Term Debt And Capital Lease Obligation | $176,868,000 | $204,716,000 | $326,113,000 | $456,588,000 |
| Long Term Debt | $164,000,000 | $190,000,000 | $309,569,000 | $440,569,000 |
| Current Debt And Capital Lease Obligation | $3,819,000 | $3,328,000 | $4,221,000 | $4,022,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $428,839,000 | $425,458,000 | $543,227,000 | $686,228,000 |
| Total Non Current Liabilities Net Minority Interest | $252,455,000 | $267,773,000 | $394,736,000 | $546,186,000 |
| Other Non Current Liabilities | $21,444,000 | $19,335,000 | $16,577,000 | $26,814,000 |
| Non Current Deferred Liabilities | $54,143,000 | $43,722,000 | $52,046,000 | $62,784,000 |
| Non Current Deferred Taxes Liabilities | $54,143,000 | $43,722,000 | $52,046,000 | $62,784,000 |
| Current Liabilities | $176,384,000 | $157,685,000 | $148,491,000 | $140,042,000 |
| Payables And Accrued Expenses | $144,669,000 | $131,471,000 | $127,042,000 | $119,476,000 |
| Payables | $95,381,000 | $87,721,000 | $86,187,000 | $82,731,000 |
| Dividends Payable | $31,044,000 | $28,510,000 | $25,717,000 | $23,129,000 |
| Total Tax Payable | $3,912,000 | $4,466,000 | $4,967,000 | $2,280,000 |
| Income Tax Payable | $3,912,000 | $4,466,000 | $4,967,000 | $2,280,000 |
| Accounts Payable | $60,425,000 | $54,745,000 | $55,503,000 | $57,322,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $1,257,413,000 | $1,149,913,000 | $1,053,984,000 | $938,284,000 |
| Total Equity Gross Minority Interest | $1,257,413,000 | $1,149,913,000 | $1,053,984,000 | $938,284,000 |
| Stockholders Equity | $1,257,413,000 | $1,149,913,000 | $1,053,984,000 | $938,284,000 |
| Gains Losses Not Affecting Retained Earnings | $41,547,000 | $-23,747,000 | $8,691,000 | $-7,154,000 |
| Other Equity Adjustments | $41,547,000 | $-23,747,000 | $8,691,000 | $-7,154,000 |
| Retained Earnings | $1,121,396,000 | $997,493,000 | $897,488,000 | $814,487,000 |
| Other | ||||
| Ordinary Shares Number | $32,058,121 | $32,527,244 | $32,254,728 | $32,152,787 |
| Share Issued | $32,058,121 | $32,527,244 | $32,254,728 | $32,152,787 |
| Tangible Book Value | $277,749,000 | $204,833,000 | $83,865,000 | $-44,520,000 |
| Invested Capital | $1,421,413,000 | $1,339,913,000 | $1,363,553,000 | $1,378,853,000 |
| Working Capital | $189,230,000 | $156,085,000 | $165,751,000 | $195,761,000 |
| Capital Lease Obligations | $16,687,000 | $18,044,000 | $20,765,000 | $20,041,000 |
| Total Capitalization | $1,421,413,000 | $1,339,913,000 | $1,363,553,000 | $1,378,853,000 |
| Additional Paid In Capital | $92,331,000 | $173,997,000 | $145,653,000 | $128,806,000 |
| Capital Stock | $2,139,000 | $2,170,000 | $2,152,000 | $2,145,000 |
| Common Stock | $2,139,000 | $2,170,000 | $2,152,000 | $2,145,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $12,868,000 | $14,716,000 | $16,544,000 | $16,019,000 |
| Current Capital Lease Obligation | $3,819,000 | $3,328,000 | $4,221,000 | $4,022,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $27,896,000 | $22,886,000 | $17,228,000 | $16,544,000 |
| Current Accrued Expenses | $49,288,000 | $43,750,000 | $40,855,000 | $36,745,000 |
| Goodwill | $816,375,000 | $780,030,000 | $778,907,000 | $769,509,000 |
| Net PPE | $322,840,000 | $299,204,000 | $295,903,000 | $290,787,000 |
| Accumulated Depreciation | $-257,726,000 | $-228,999,000 | $-212,796,000 | $-189,483,000 |
| Gross PPE | $580,566,000 | $528,203,000 | $508,699,000 | $480,270,000 |
| Construction In Progress | $95,229,000 | $77,508,000 | $59,981,000 | $79,928,000 |
| Other Properties | $356,514,000 | $332,051,000 | $332,568,000 | $298,283,000 |
| Buildings And Improvements | $116,395,000 | $106,954,000 | $104,363,000 | $90,644,000 |
| Land And Improvements | $12,428,000 | $11,690,000 | $11,787,000 | $11,415,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $83,064,000 | $80,973,000 | $66,044,000 | $72,048,000 |
| Work In Process | $6,527,000 | $4,510,000 | $3,960,000 | $3,143,000 |
| Raw Materials | $41,858,000 | $45,319,000 | $39,517,000 | $44,477,000 |
| Machinery Furniture Equipment | - | - | - | $278,851,000 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $173,067,000 | $146,338,000 | $145,869,000 | $88,591,000 |
| Operating Activities | ||||
| Operating Cash Flow | $216,556,000 | $181,999,000 | $183,761,000 | $138,536,000 |
| Cash Flow From Continuing Operating Activities | $216,556,000 | $181,999,000 | $183,761,000 | $138,536,000 |
| Operating Gains Losses | $-738,000 | $1,564,000 | $6,298,000 | $1,280,000 |
| Investing Activities | ||||
| Capital Expenditure | $-43,489,000 | $-35,661,000 | $-37,892,000 | $-49,945,000 |
| Investing Cash Flow | $-43,891,000 | $-59,736,000 | $-34,813,000 | $-416,014,000 |
| Cash Flow From Continuing Investing Activities | $-43,891,000 | $-59,736,000 | $-34,813,000 | $-416,014,000 |
| Net Other Investing Changes | $274,000 | $359,000 | $1,881,000 | $206,000 |
| Capital Expenditure Reported | $-43,489,000 | $-35,661,000 | $-37,892,000 | $-49,945,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-107,636,000 | $-5,682,000 | $-4,469,000 | $-35,423,000 |
| Financing Cash Flow | $-152,810,000 | $-133,815,000 | $-153,321,000 | $246,679,000 |
| Cash Flow From Continuing Financing Activities | $-152,810,000 | $-133,815,000 | $-153,321,000 | $246,679,000 |
| Cash Dividends Paid | $-28,287,000 | $-25,576,000 | $-22,872,000 | $-20,713,000 |
| Common Stock Dividend Paid | $-28,287,000 | $-25,576,000 | $-22,872,000 | $-20,713,000 |
| Net Common Stock Issuance | $-107,636,000 | $-5,682,000 | $-4,469,000 | $-35,423,000 |
| Net Other Financing Charges | - | - | - | $-1,232,000 |
| Other | ||||
| Repayment Of Debt | $-114,194,000 | $-145,785,000 | $-149,222,000 | $-134,165,000 |
| Issuance Of Debt | $88,000,000 | $26,000,000 | $18,000,000 | $435,000,000 |
| Interest Paid Supplemental Data | $10,603,000 | $17,697,000 | $25,933,000 | $11,879,000 |
| Income Tax Paid Supplemental Data | $37,749,000 | $42,643,000 | $35,725,000 | $33,016,000 |
| End Cash Position | $74,570,000 | $49,515,000 | $64,447,000 | $66,560,000 |
| Beginning Cash Position | $49,515,000 | $64,447,000 | $66,560,000 | $103,239,000 |
| Effect Of Exchange Rate Changes | $5,200,000 | $-3,380,000 | $2,260,000 | $-5,880,000 |
| Changes In Cash | $19,855,000 | $-11,552,000 | $-4,373,000 | $-30,799,000 |
| Proceeds From Stock Option Exercised | $9,307,000 | $17,228,000 | $5,242,000 | $3,212,000 |
| Common Stock Payments | $-107,636,000 | $-5,682,000 | $-4,469,000 | $-35,423,000 |
| Net Issuance Payments Of Debt | $-26,194,000 | $-119,785,000 | $-131,222,000 | $300,835,000 |
| Net Long Term Debt Issuance | $-26,194,000 | $-119,785,000 | $-131,222,000 | $300,835,000 |
| Long Term Debt Payments | $-114,194,000 | $-145,785,000 | $-149,222,000 | $-134,165,000 |
| Long Term Debt Issuance | $88,000,000 | $26,000,000 | $18,000,000 | $435,000,000 |
| Net Investment Purchase And Sale | $0 | $0 | $2,740,000 | $0 |
| Sale Of Investment | $0 | $0 | $2,740,000 | $0 |
| Net Business Purchase And Sale | $-676,000 | $-24,434,000 | $-1,542,000 | $-366,275,000 |
| Purchase Of Business | $-676,000 | $-24,434,000 | $-1,542,000 | $-366,275,000 |
| Change In Working Capital | $-7,463,000 | $-6,117,000 | $20,010,000 | $-25,222,000 |
| Change In Other Working Capital | $-205,000 | $1,802,000 | $2,499,000 | $-127,000 |
| Change In Payables And Accrued Expense | $11,292,000 | $9,065,000 | $3,552,000 | $-15,543,000 |
| Change In Prepaid Assets | $-1,332,000 | $225,000 | $-3,540,000 | $1,870,000 |
| Change In Inventory | $3,635,000 | $-22,791,000 | $10,530,000 | $-7,804,000 |
| Change In Receivables | $-20,853,000 | $5,582,000 | $6,969,000 | $-3,618,000 |
| Changes In Account Receivables | $-20,853,000 | $5,582,000 | $6,969,000 | $-3,618,000 |
| Stock Based Compensation | $18,057,000 | $16,675,000 | $16,052,000 | $13,224,000 |
| Provisionand Write Offof Assets | $-97,000 | $299,000 | $37,000 | $401,000 |
| Deferred Tax | $6,262,000 | $-6,779,000 | $-10,814,000 | $-8,362,000 |
| Deferred Income Tax | $6,262,000 | $-6,779,000 | $-10,814,000 | $-8,362,000 |
| Depreciation Amortization Depletion | $45,690,000 | $47,973,000 | $54,935,000 | $51,848,000 |
| Depreciation And Amortization | $45,690,000 | $47,973,000 | $54,935,000 | $51,848,000 |
| Net Foreign Currency Exchange Gain Loss | $-680,000 | $-100,000 | $-733,000 | $914,000 |
| Net Income From Continuing Operations | $154,845,000 | $128,475,000 | $108,543,000 | $105,367,000 |
| Other Non Cash Items | - | $-91,000 | $-11,300,000 | - |
| Asset Impairment Charge | - | - | $7,031,000 | $23,000 |
| Sale Of Business | - | - | - | - |
Fetched: 2026-06-15